Becton Dickinson (BDX) Cash from Operations (2009 - 2026)
Becton Dickinson's (BDX) quarterly Cash from Operations came in at $776.0 million in Q2 2026, down 28.74% year-over-year from $1.1 billion in Q2 2025, and up 15.65% quarter-over-quarter from $671.0 million in Q1 2026.
Analysis
Becton Dickinson (BDX) Cash from Operations (2009 - 2026) Analysis & Trends
Becton Dickinson (BDX) has reported Cash from Operations for 18 consecutive years, with $776.0 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Cash from Operations fell 28.74% year-over-year to $776.0 million in Q2 2026; TTM through Jun 2026 was $4.0 billion, a 43.54% increase from a year earlier, with the FY2025 full-year figure at $3.4 billion, down 10.77% from the prior year.
- Cash from Operations was $776.0 million for Q2 2026 at Becton Dickinson, up from $671.0 million in the prior quarter.
- Over five years, Cash from Operations peaked at $1.9 billion in Q3 2025 and troughed at -$204.0 million in Q1 2025.
- A 5-year average of $794.9 million and a median of $734.5 million in 2024 frame the typical range for Cash from Operations.
- Across the five-year window, Cash from Operations plunged 139.69% in 2025 and soared 428.92% in 2026, its largest moves.
- Over 5 years, Cash from Operations stood at $399.0 million in 2022, then soared by 114.29% to $855.0 million in 2023, then declined by 18.95% to $693.0 million in 2024, then fell by 5.19% to $657.0 million in 2025, then rose by 18.11% to $776.0 million in 2026.
- The last three Cash from Operations figures came in at $776.0 million (Q2 2026), $671.0 million (Q1 2026), and $657.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Operations (Qtr) |
|---|---|---|---|---|---|
| 1 | Becton Dickinson | 48.41 Bn | 47.55 Bn | 2.32 Bn | 776.00 Mn |
| 2 | Medline | 27.78 Bn | 25.10 Bn | 2.22 Bn | 715.00 Mn |
| 3 | West Pharmaceutical Services | 24.42 Bn | 23.98 Bn | 329.20 Mn | 124.00 Mn |
| 4 | Baxter International | 12.49 Bn | 10.34 Bn | 1.03 Bn | 297.00 Mn |
| 5 | Stevanato Group S.p.A | 5.70 Bn | 5.59 Bn | 100.91 Mn | 37.08 Mn |
| 6 | Acme United | 235.29 Mn | 230.25 Mn | 26.69 Mn | 13.12 Mn |
| 7 | Rockwell Medical | 31.39 Mn | 6.60 Mn | 3.24 Mn | 2.11 Mn |
| 8 | Retractable Technologies | 21.15 Mn | -18.72 Mn | 190,852.00 | -1.73 Mn |
| 9 | United Health Products | 8.85 Mn | 8.82 Mn | - | -138,013.00 |
| 10 | Cuprina Holdings (Cayman) | 7.88 Mn | 4.76 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 776.00 Mn |
| Mar 31, 2026 | 671.00 Mn |
| Dec 31, 2025 | 657.00 Mn |
| Sep 30, 2025 | 1.85 Bn |
| Jun 30, 2025 | 1.09 Bn |
| Mar 31, 2025 | -204.00 Mn |
| Dec 31, 2024 | 693.00 Mn |
| Sep 30, 2024 | 1.18 Bn |
| Jun 30, 2024 | 1.30 Bn |
| Mar 31, 2024 | 514.00 Mn |
| Dec 31, 2023 | 855.00 Mn |
| Sep 30, 2023 | 1.33 Bn |
| Jun 30, 2023 | 1.08 Bn |
| Mar 31, 2023 | 185.00 Mn |
| Dec 31, 2022 | 399.00 Mn |
| Sep 30, 2022 | 973.00 Mn |
| Jun 30, 2022 | 678.00 Mn |
| Mar 31, 2022 | 290.00 Mn |
| Dec 31, 2021 | 530.00 Mn |
| Sep 30, 2021 | 841.00 Mn |